Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Effect of Eicosapentaenoic Acid (EPA) on Markers of Atherothrombosis in Patients With Type-2 Diabetes

NCT06129526 is registered in ClinicalTrials.gov with University of Ioannina as lead sponsor.

NCT NCT06129526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06129526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Effect of Eicosapentaenoic Acid (EPA) on Markers of Atherothrombosis in Patients With Type-2 Diabetes
Lead sponsor
University of Ioannina
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2023
Completion date
December 31, 2024
Enrollment
450 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, diabetes type 2, hypertriglyceridemia